Fresenius Medical Care AG

XNYS

Last traded price · USD

$23.19

+6.72%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:30 IST · A quote does not mean the product is available to trade on your account.

Day's open: $22.67
Previous close: $21.73
Volume: 2.3M
Day's high: $23.24
Day's low: $22.62

In brief

Fresenius Medical Care AG is a US-listed company listed on the New York Stock Exchange, valued at about $12.34B.
Its shares closed at $23.19 on 4 Nov 2026, down 4.5% over the past year.
From India you can buy FMS in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Fresenius Medical Care AG (FMS) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole FMS share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade FMS options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Above its 50- and 200-day averages
The 4 Nov 2026 close of $23.19 was 3.9% above its 50-day average ($22.33) and 1.3% above its 200-day average ($22.89). It has closed above the 200-day for 1 session, since 4 Nov 2026. The 50-day average crossed below the 200-day on 12 Oct 2026, 17 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Rose 6.7% on 4 Nov 2026
The 4 Nov 2026 gain of 6.7% was 5.1× its average daily move of 1.3% over the past year, and its largest one-day gain since 6 May 2025.
Daily closes, split-adjusted · as of 4 Nov 2026
Behind SPY over 1 year
1 month: +3.4% (SPY −1.6%). 3 months: −2.9% (SPY −0.4%). 1 year: −4.5% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: FMS, SPY · as of 4 Nov 2026
50% of the way up its 52-week range
Closed at $23.19 on 4 Nov 2026: 12.2% below the 52-week high of $26.42 (3 Aug 2026) and 15.8% above the low of $20.02 (5 May 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Volume 1.9× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 2.3M shares was 1.9× the average of the 30 sessions before it (1.2M), as the price rose 6.7%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+3.4%

6 months+10.4%

1 year−4.5%

5 years−32.2%

Newswire

About

Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.

Website

Notable moves

March 5, 2024
+11.19%
October 11, 2023
−17.57%
July 28, 2022
−14.10%

Fresenius Medical Care AG

XNYS

Last traded price · USD

$23.19

+6.72%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:30 IST · A quote does not mean the product is available to trade on your account.

Day's open: $22.67
Previous close: $21.73
Volume: 2.3M
Day's high: $23.24
Day's low: $22.62

In brief

Fresenius Medical Care AG is a US-listed company listed on the New York Stock Exchange, valued at about $12.34B.
Its shares closed at $23.19 on 4 Nov 2026, down 4.5% over the past year.
From India you can buy FMS in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Fresenius Medical Care AG (FMS) shares from India?

Do I need the price of a whole FMS share to invest?

How much can I invest in US stocks in a year?

Can I trade FMS options or futures?

Insights

Quotes run fifteen minutes behind.

Above its 50- and 200-day averages
The 4 Nov 2026 close of $23.19 was 3.9% above its 50-day average ($22.33) and 1.3% above its 200-day average ($22.89). It has closed above the 200-day for 1 session, since 4 Nov 2026. The 50-day average crossed below the 200-day on 12 Oct 2026, 17 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Rose 6.7% on 4 Nov 2026
The 4 Nov 2026 gain of 6.7% was 5.1× its average daily move of 1.3% over the past year, and its largest one-day gain since 6 May 2025.
Daily closes, split-adjusted · as of 4 Nov 2026
Behind SPY over 1 year
1 month: +3.4% (SPY −1.6%). 3 months: −2.9% (SPY −0.4%). 1 year: −4.5% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: FMS, SPY · as of 4 Nov 2026
50% of the way up its 52-week range
Closed at $23.19 on 4 Nov 2026: 12.2% below the 52-week high of $26.42 (3 Aug 2026) and 15.8% above the low of $20.02 (5 May 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Volume 1.9× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 2.3M shares was 1.9× the average of the 30 sessions before it (1.2M), as the price rose 6.7%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+3.4%

6 months+10.4%

1 year−4.5%

5 years−32.2%

Newswire

About

Website

Notable moves

March 5, 2024
+11.19%
October 11, 2023
−17.57%
July 28, 2022
−14.10%

Fresenius Medical Care AG

Fresenius Medical Care AG in brief

Above its 50- and 200-day averages

Rose 6.7% on 4 Nov 2026

Behind SPY over 1 year

50% of the way up its 52-week range

Volume 1.9× its 30-session average on 4 Nov 2026

Fresenius Medical Care AG

Fresenius Medical Care AG in brief

Above its 50- and 200-day averages

Rose 6.7% on 4 Nov 2026

Behind SPY over 1 year

50% of the way up its 52-week range

Volume 1.9× its 30-session average on 4 Nov 2026